Release Date: 18/09/17 09:35 Summary: Updated forbearance agreement with Noteholders Price Sensitive: No Download Document 188.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%